# Aktis Oncology IPO (AKTS): price, date and first-day trading

> Aktis Oncology (AKTS) priced its IPO at $18.00 a share and has traded on Nasdaq since Jan 9, 2026.

Canonical: https://massive.com/quote/akts/ipo
Data as of: 2026-11-19T09:12:59.071Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## AKTS price

| Figure | Value |
| --- | --- |
| Price | $16.10 |
| Change from the IPO price | -10.56% |
| Change today | -1.29% |

## How AKTS did against the market

AKTS against the market, from its first trade at 11:10 ET to the last trade of the session.

| Measure | Value |
| --- | --- |
| AKTS from its first trade | -17.83% |
| Against the market (QQQ) | -18.0 pts |

## The IPO scoreboard

AKTS against other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.

| IPO | Raised | First trade | Day 1 close | Day 5 | Day 30 |
| --- | --- | --- | --- | --- | --- |
| Aktis Oncology | $317.7M | +50.00% | +23.26% | +13.75% | +7.83% |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |

## The offering

| Term | Value |
| --- | --- |
| Expected price range | $16 to $18 |
| IPO price | $18.00 |
| Shares offered | 17.65M |
| Money raised | $317.7M |
| Listing date | Jan 9, 2026 |
| Exchange | Nasdaq |
| Security | Ordinary Shares |

## Where AKTS ranks

The company's market cap against the largest US-listed companies.

| Company | Market cap |
| --- | --- |
| AAPL | $5.12T |
| MSFT | $3.77T |
| NVDA | $3.65T |
| GOOGL | $3.47T |
| AMZN | $2.9T |
| TSM | $1.88T |
| AVGO | $1.69T |
| META | $1.58T |
| TSLA | $1.52T |
| BRK.B | $1.22T |
| AKTS | $898.35M |

## Insider buying and selling after the IPO

From Jan 9, 2026 to Nov 19, 2026, 3 AKTS insiders reported open-market sales of $3.2M across 5 filings; no open-market purchases were filed.

- Akos Czibere, Chief Medical Officer: sold $1.4M, filed Jul 10, 2026
- Shulamit Ron-Bigger, Chief Operating Officer: sold $1.4M, filed Jul 10, 2026
- Akos Czibere, Chief Medical Officer: sold $258.6K, filed Sep 24, 2026
- Ken Herrmann, Director: sold $119.3K, filed Jul 21, 2026
- Ken Herrmann, Director: sold $77.3K, filed Jul 20, 2026

Sales made in the offering itself are left out.

[Who traded and when](https://massive.com/quote/akts/insider-trading.md)

## AKTS news

- [Does Aktis (AKTS) Have the Potential to Rally 105.62% as Wall Street Analysts Expect?](https://www.zacks.com/stock/news/3028106/does-aktis-akts-have-the-potential-to-rally-105-62-as-wall-street-analysts-expect?cid=CS-ZC-FT-fundamental_analysis|consensus_price_target-3028106) · Zacks Investment Research · Nov 11, 2026
- [Why This Biotech Fund Opened a $9 Million Position in a Newly Public Cancer Company](https://www.fool.com/coverage/filings/2026/05/13/why-this-biotech-fund-opened-a-usd9-million-position-in-a-newly-public-cancer-company/?source=iedfolrf0000001) · The Motley Fool · May 13, 2026
- [Aktis Oncology to Present at the BofA Securities Health Care Conference](https://www.globenewswire.com/news-release/2026/05/06/3288736/0/en/Aktis-Oncology-to-Present-at-the-BofA-Securities-Health-Care-Conference.html) · GlobeNewswire Inc. · May 6, 2026
- [Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting](https://www.globenewswire.com/news-release/2026/04/21/3278532/0/en/Aktis-Oncology-Announces-Presentation-of-First-Clinical-Imaging-and-Dosimetry-Data-for-AKY-2519-at-the-2026-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html) · GlobeNewswire Inc. · Apr 21, 2026
- [A Fresh IPO That Long-Term Investors Shouldn’t Ignore](https://www.investing.com/analysis/a-fresh-ipo-that-longterm-investors-shouldnt-ignore-200673246) · Investing.com · Jan 14, 2026
- [Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares](https://www.benzinga.com/pressreleases/26/01/g49868342/aktis-oncology-announces-closing-of-upsized-initial-public-offering-and-full-exercise-of-underwrit?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel) · Benzinga · Jan 13, 2026

## Filings and the company

Material events that Aktis Oncology has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · Quarterly earnings ([filing](https://www.sec.gov/Archives/edgar/data/2035832/0001193125-26-457045.txt))
- Apr 16, 2026 · Director departure ([filing](https://www.sec.gov/Archives/edgar/data/2035832/0001193125-26-158944.txt))
- Jan 12, 2026 · Charter amendment ([filing](https://www.sec.gov/Archives/edgar/data/2035832/0001193125-26-010354.txt))
- Dec 17, 2024 · Voluntary bankruptcy ([filing](https://www.sec.gov/Archives/edgar/data/1584754/0001213900-24-109749.txt))
- Dec 16, 2024 · Debt acceleration ([filing](https://www.sec.gov/Archives/edgar/data/1584754/0001213900-24-109364.txt))

## FAQ

### What was the Aktis Oncology IPO price?

$18.00 a share.

### When did Aktis Oncology go public?

Aktis Oncology listed on Nasdaq on Jan 9, 2026 under the ticker AKTS.

### How much did the Aktis Oncology IPO raise?

$317.7M, before any underwriters' option.

### How did Aktis Oncology open on its first day?

AKTS first traded at $27.00, +50.00% from the IPO price of $18.00.

### How did AKTS close on its first day?

Its last regular-session trade was $22.19, +23.26% from the IPO price of $18.00.

### What was the AKTS first-day trading range?

$19.33 to $29.16 in the regular session.

### How many AKTS shares traded on the first day?

3.02M shares in the regular session.

### How many shares did Aktis Oncology sell in its IPO?

17.65M shares.

### How did AKTS do against the market on its first day?

AKTS fell 17.8% from its first trade to the last trade of the session. That is 18.0 points worse than the market (QQQ, the Nasdaq-100 ETF).

### What exchange is AKTS listed on?

Aktis Oncology lists on Nasdaq under the ticker AKTS.

## Live data

The IPO record and the price come from the Massive API.

- `GET https://api.massive.com/vX/reference/ipos?ticker=AKTS`
- `GET https://api.massive.com/v3/snapshot?ticker.any_of=AKTS`
- `GET https://api.massive.com/v2/aggs/ticker/AKTS/range/5/minute/{date}/{date}`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Markets overview](https://massive.com/quote/index.md)
- [Insider trading](https://massive.com/quote/insider-trading.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
